EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Limited Short-Term Evolution of SARS-CoV-2 RNA-Dependent RNA Polymerase under Remdesivir Exposure in Upper Respiratory Compartments

Vladimir Novitsky, Curt G Beckwith, Kristin Carpenter-Azevedo, Jimin Shin iD, Joel Hague, Soya Sam, Jon Steingrimsson, Richard C Huard, Kevin Lethbridge, Sujata Sahu, Kim Rapoza, Karen Chandran und 8 weitere

Viruses · 2024

DOI: 10.3390/v16101511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Vladimir Novitsky und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Warren Alpert Medical School, Brown University, Providence, RI 02912, USA. Hauptthemen laut MEDLINE: Alanine, SARS-CoV-2, Adenosine Monophosphate, COVID-19 Drug Treatment. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences (United States).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The extent of the SARS-CoV-2 short-term evolution under Remdesivir (RDV) exposure and whether it varies across different upper respiratory compartments are not fully understood.

Methods

Patients hospitalized for COVID-19, with or without RDV therapy, were enrolled and completed up to three visits, in which they provided specimens from four respiratory compartments. Near full-length genome SARS-CoV-2 sequences were obtained from viral RNA, standard lineage and variant assignments were performed, and viral mutations in the RNA-dependent RNA polymerase (RdRp) region—the RDV target gene—were detected and compared between participants with and without RDV, across the four compartments, within participants across visits, and versus a larger sequence dataset. The statistical analysis used a generalized linear mixed-effects model.

Results

A total of 139 sequences were obtained from 37 out of the 44 (84%) enrolled participants. The genotyping success varied across respiratory compartments, which ranged from 42% with oropharyngeal specimens to 67% with nasopharyngeal specimens and showed improvement with higher viral loads. No RdRp mutations known to be associated with RDV resistance were identified, and for 34 detected mutations at 32 amino acid positions that are not known as RDV-associated, there was no evidence of any associations with the RDV exposure, respiratory compartment, or time. At least 1 of these 34 mutations were detected in all participants, and some differed from the larger sequence dataset.

Conclusions

This study highlighted the SARS-CoV-2 short-term genomic stability within hosts and across upper respiratory compartments, which suggests a lack of evolution of RDV resistance over time. This contributes to our understanding of SARS-CoV-2 genomic dynamics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlanineSARS-CoV-2Adenosine MonophosphateCOVID-19 Drug TreatmentAntiviral AgentsCOVID-19MutationHumansFemaleMaleMiddle AgedAdultEvolution, MolecularAgedNasopharynxCoronavirus RNA-Dependent RNA PolymeraseRNA-Dependent RNA PolymeraseOropharynxViral LoadRNA, ViralGenome, ViralDrug Resistance, Viral

Stichwörter der Autor:innen

RdRpSARS-CoV-2drug resistanceremdesivirrespiratory compartments

Substanzen

remdesivirAlanineAdenosine MonophosphateAntiviral AgentsCoronavirus RNA-Dependent RNA PolymeraseRNA-Dependent RNA PolymeraseRNA, Viral

Autor:innen und Institutionen

  • Department of Medicine, Warren Alpert Medical School, Brown University, Providence, RI 02912, USA.
  • State Health Laboratories, Rhode Island Department of Health, Providence, RI 02912, USA.
  • School of Medicine, University of Connecticut, Farmington, CT 06030, USA.
  • Department of Biostatistics, School of Public Health, Brown University, Providence, RI 02912, USA.
  • Rhode Island Hospital, Providence, RI 02912, USA.
  • The Miriam Hospital, Providence, RI 02912, USA.

ORCID-Profile: Jimin Shin, Rami Kantor

Förderung

  • Gilead Sciences (United States)

Zitieren

APA

Novitsky, V., Beckwith, C. G., Carpenter-Azevedo, K., Shin, J., Hague, J., Sam, S., Steingrimsson, J., Huard, R. C., Lethbridge, K., Sahu, S., Rapoza, K., Chandran, K., Bazerman, L., Hipolito, E., Diaz, I., Carnevale, D., Guang, A., Gillani, F., Caliendo, A. M., & Kantor, R. (2024). Limited Short-Term Evolution of SARS-CoV-2 RNA-Dependent RNA Polymerase under Remdesivir Exposure in Upper Respiratory Compartments. Viruses. https://doi.org/10.3390/v16101511

Vancouver

Novitsky V, Beckwith CG, Carpenter-Azevedo K, Shin J, Hague J, Sam S, et al. Limited Short-Term Evolution of SARS-CoV-2 RNA-Dependent RNA Polymerase under Remdesivir Exposure in Upper Respiratory Compartments. Viruses. 2024. doi:10.3390/v16101511

BibTeX
@article{Novitsky2024,
  author = {Novitsky, Vladimir and Beckwith, Curt G and Carpenter-Azevedo, Kristin and Shin, Jimin and Hague, Joel and Sam, Soya and Steingrimsson, Jon and Huard, Richard C and Lethbridge, Kevin and Sahu, Sujata and Rapoza, Kim and Chandran, Karen and Bazerman, Lauri and Hipolito, Evelyn and Diaz, Isabella and Carnevale, Daniella and Guang, August and Gillani, Fizza and Caliendo, Angela M and Kantor, Rami},
  title = {Limited Short-Term Evolution of SARS-CoV-2 RNA-Dependent RNA Polymerase under Remdesivir Exposure in Upper Respiratory Compartments},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16101511}
}
Kostenlos starten →